The alpha-3 polypeptide chain of laminin 5: Insight into wound healing responses from the study of genodermatoses

Clinical and Experimental Dermatology

Volumn 30, Issue 4, 2005, Pages 398-404

  Hamill, K J ^a   McLean, W H I ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN TYPE 7; EPILIGRIN; KALININ; LAMININ ALPHA3; LAMININ BETA3; LAMININ GAMMA2; MITOGEN ACTIVATED PROTEIN KINASE; POLYPEPTIDE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ALPHA CHAIN; ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; CYTOSKELETON; DERMOEPIDERMAL JUNCTION; ELECTRON MICROSCOPY; EPIDERMOLYSIS BULLOSA; GENE; GENE EXPRESSION; GENODERMATOSIS; GRANULATION TISSUE; HEMIDESMOSOME; HUMAN; HUMAN TISSUE; KERATINOCYTE; LAMA3 GENE; LARYNGOONYCHOCUTANEOUS SYNDROME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SHABBIR SYNDROME; SIGNAL TRANSDUCTION; WOUND HEALING;

CELL ADHESION MOLECULES; EPIDERMOLYSIS BULLOSA, JUNCTIONAL; HUMANS; SKIN DISEASES, GENETIC; WOUND HEALING;

EID: 20644440622     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01842.x     Document Type: Review

References (26)

1. Miosge N, Kluge JG, Studzinski A et al. In situ-RT-PCR and immunohistochemistry for the localisation of the mRNA of the alpha 3 chain of laminin and laminin-5 during human organogenesis. Anat Embryol (Berl) 2002; 205: 355-63.
2. McMillan JR, Akiyama M, Shimizu H. Ultrastructural orientation of laminin 5 in the epidermal basement membrane: an updated model for basement membrane organization. J Histochem Cytochem 2003; 51: 1299-306.
3. Marinkovich MP, Lunstrum GP, Burgeson RE. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 1992; 267: 17900-6.
4. Gonzales M, Haan K, Baker SE et al. A cell signal pathway involving laminin-5, alpha3beta1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation. Mol Biol Cell 1999; 10: 259-70.
5. Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol 1998; 141: 255-65.
6. Goldfinger LE, Hopkinson SB, deHart GW et al. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 1999; 112: 2615-29.
7. Utani A, Nomizu M, Matsuura H et al. A unique sequence of the laminin alpha 3 G domain binds to heparin and promotes cell adhesion through syndecan-2 and -4. J Biol Chem 2001; 276: 28779-88.
8. Goldfinger LE, Jiang L, Hopkinson SB et al. Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha 3 subunit of laminin-5. J Biol Chem 2000; 275: 34887-93.
9. Okamoto O, Bachy S, Odenthal U et al. Normal human keratinocytes bind to the alpha3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1. J Biol Chem 2003; 278: 44168-77.
10. Chen M, Marinkovich MP, Jones JC et al. NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol 1999; 112: 177-83.
11. Vidal F, Baudoin C, Miquel C et al. Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Genomics 1995; 30: 273-80.
12. Matsui C, Pereira P, Wang CK et al. Extent of laminin-5 assembly and secretion effect junctional epidermolysis bullosa phenotype. J Exp Med 1998; 187: 1273-83.
13. Spirito F, Chavanas S, Prost-Squarcioni C et al. Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation. J Biol Chem 2001; 276: 18828-35.
14. Meneguzzi G, Marinkovich MP, Aberdam D et al. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp Dermatol 1992; 1: 221-9.
15. Ashton GH, Sorelli P, Mellerio JE et al. Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia. Br J Dermatol 2001; 144: 408-14.
16. Shabbir G, Kazmi A. Laryngo-onchyo-cutaneous syndromme - a study of 22 cases. Biomedica 1986; 2: 15-25.
17. Phillips RJ, Atherton DJ, Gibbs ML et al. Laryngo-onycho-cutaneous syndrome: an inherited epithelial defect. Arch Dis Child 1994; 70: 319-26.
18. Ainsworth JR, Spencer AF, Dudgeon J et al. Laryngeal and ocular granulation tissue formation in two Punjabi children: LOGIC syndrome. Eye 1991; 5: 717-22.
19. Ryan MC, Tizard R, VanDevanter DR et al. Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 1994; 269: 22779-87.
20. McLean WHI, Irvine AD, Hamill KJ et al. An unusual N terminal deletion of the alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onchyo-cutaneous syndrome. Human Mol Genet 2003; 12: 2395-409.
21. Doliana R, Bellina I, Bucciotti F et al. The human alpha3b is a 'full-sized' laminin chain variant with a more wide-spread tissue expression than the truncated alpha3a. FEBS Lett 1997; 417: 65-70.
22. Oliveira CC, McCarthy JE. The relationship between eukaryotic translation and mRNA stability. A short upstream open reading frame strongly inhibits translational initiation and greatly accelerates mRNA degradation in the yeast Saccharomyces cerevisiae. J Biol Chem 1995; 270: 8936-43.
23. Strauss R, Bate J, Clayton T et al. A child with laryngo-onycho-cutaneous syndrome successfully treated with thalidomide. Br J Dermatol 2003; 149 (Suppl. 64): 71-86.
24. D'Amato RJ, Loughnan MS, Flynn E et al Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-5.
25. Or R, Feferman R, Shoshan S. Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs. Exp Hematol 1998; 26: 217-21.
26. Sampaio EP, Sarno EN, Galilly R et al. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991; 173: 699-703.